MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $996,000 | -23.9% | 35,866 | -9.0% | 0.03% | -23.8% |
Q1 2019 | $1,308,000 | +12.3% | 39,396 | -1.7% | 0.04% | +2.4% |
Q4 2018 | $1,165,000 | -36.3% | 40,067 | +0.7% | 0.04% | -24.1% |
Q3 2018 | $1,830,000 | +12.5% | 39,791 | -8.6% | 0.05% | +12.5% |
Q2 2018 | $1,626,000 | +23.6% | 43,516 | -2.3% | 0.05% | +6.7% |
Q1 2018 | $1,316,000 | -68.2% | 44,541 | -63.1% | 0.04% | -68.1% |
Q4 2017 | $4,140,000 | +24.8% | 120,546 | +31.4% | 0.14% | +24.8% |
Q3 2017 | $3,318,000 | -15.9% | 91,715 | -39.9% | 0.11% | -23.6% |
Q2 2017 | $3,946,000 | +34.6% | 152,715 | 0.0% | 0.15% | +38.3% |
Q1 2017 | $2,932,000 | +46.9% | 152,715 | +27.6% | 0.11% | +57.4% |
Q4 2016 | $1,996,000 | -19.0% | 119,715 | 0.0% | 0.07% | +54.5% |
Q3 2016 | $2,464,000 | -4.9% | 119,715 | +41.3% | 0.04% | -4.3% |
Q2 2016 | $2,592,000 | – | 84,715 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |